Ironwood Pharmaceuticals, Inc.
IRWD
$0.8396
$0.0354.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -54.56% | -1.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -54.56% | -1.14% | |||
| Cost of Revenue | 134.96% | -363.11% | |||
| Gross Profit | -91.89% | 173.65% | |||
| SG&A Expenses | -27.78% | -6.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.36% | -10.55% | |||
| Operating Income | -133.42% | 23.05% | |||
| Income Before Tax | -251.16% | 38.15% | |||
| Income Tax Expenses | -94.88% | 58.41% | |||
| Earnings from Continuing Operations | -1,757.18% | -38.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,757.18% | -38.12% | |||
| EBIT | -133.42% | 23.05% | |||
| EBITDA | -131.42% | 20.67% | |||
| EPS Basic | -1,746.81% | -38.16% | |||
| Normalized Basic EPS | -172.96% | 38.68% | |||
| EPS Diluted | -1,746.81% | -29.50% | |||
| Normalized Diluted EPS | -172.96% | 39.09% | |||
| Average Basic Shares Outstanding | 0.96% | -0.16% | |||
| Average Diluted Shares Outstanding | 0.96% | -0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||